Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,290 | -7,929 | -4,838 | -58,923 | -54,852 |
| Depreciation Amortization | 1 | 0 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | -335 | -310 | -187 | 188 | 119 |
| Other Working Capital | -688 | -661 | -908 | 1,138 | 562 |
| Other Operating Activity | 11,231 | 5,962 | 3,993 | 57,192 | 53,858 |
| Operating Cash Flow | $-4,081 | $-2,938 | $-1,939 | $-405 | $-313 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | -3 | N/A | N/A |
| Investing Cash Flow | $-5 | $-5 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -50 | 253 | -50 | 886 | 431 |
| Debt Repayment | N/A | N/A | -151 | N/A | N/A |
| Common Stock Issued | 4,315 | 3,315 | 3,315 | N/A | N/A |
| Other Financing Activity | 209 | -76 | -587 | -395 | -13 |
| Financing Cash Flow | $4,474 | $3,492 | $2,527 | $491 | $418 |
| Exchange Rate Effect | 44 | 0 | 5 | -95 | -75 |
| Beginning Cash Position | 12 | 12 | 12 | 21 | 21 |
| End Cash Position | 444 | 561 | 603 | 12 | 51 |
| Net Cash Flow | $432 | $549 | $591 | $-9 | $30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,081 | -2,938 | -1,939 | -405 | -313 |
| Capital Expenditure | -5 | -5 | -3 | N/A | N/A |
| Free Cash Flow | -4,086 | -2,943 | -1,942 | -405 | -313 |